10 completed, 4 recruiting, 2 active not recruiting, 1 not yet recruiting. 18 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 18 | Completed 10, Recruiting 4, Active not recruiting 2, Not yet recruiting 1, Terminated 1 |
| Phase 2 | 1 | Not yet recruiting 1 |
Follow Rhabdomyosarcoma: new trials by email Literature Review of Rhabdomyosarcoma trials Research Report on Rhabdomyosarcoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS) Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Rhabdomyosarcoma | Phase 3 | Recruiting | Children's Oncology Group | 342 | 2026-07-14 | 2026-08-25 |
| Study Comparing Two Serums With Intense Pulsed Light for the Treatment of Moderate to Severe Photodamage and Crepiness on the Forearms Right Arm treated with Active Re-Q Pro-Longevity Serum and Intense Pulsed Light Therapy, Left Arm treated with vehicle serum and Intense Pulsed Light Therapy - Photodamaged Skin | Phase 2 / Phase 3 | Not yet recruiting | Goldman, Butterwick, Fitzpatrick and Groff | 20 | 2026-07-10 | 2026-07-07 |
| Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma Biopsy Procedure, Bone Scan, Computed Tomography - Embryonal Rhabdomyosarcoma, Fusion-Negative Alveolar Rhabdomyosarcoma | Phase 3 | Recruiting | Children's Oncology Group | 205 | 2022-08-04 | 2026-08-25 |
| A Study to Compare Early Use of Vinorelbine and Maintenance Therapy for Patients With High Risk Rhabdomyosarcoma Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Alveolar Rhabdomyosarcoma, Botryoid-Type Embryonal Rhabdomyosarcoma | Phase 3 | Active not recruiting | Children's Oncology Group | 113 | 2021-09-14 | 2026-07-30 |
| Chemo-immunotherapy in Patients Under 18 Years of Age With Bone and Soft Tissue Sarcomas dinutuximab beta - Bone Sarcoma, Embryonal Rhabdomyosarcoma | Phase 3 | Recruiting | N.N. Petrov National Medical Research Center of Oncology | 40 | 2021-05-20 | 2024-11-01 |
| A Prospective Clinical Cohort Study on Stratified Treatment of Rhabdomyosarcoma Based on Risk Factors. VAC,VAC/VII,CAV/IE - Rhabdomyosarcoma, Pediatric Cancer | Phase 3 | Recruiting | Yizhuo Zhang | 300 | 2017-01-30 | 2025-02-20 |
| Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma Cyclophosphamide, Dactinomycin, Irinotecan Hydrochloride - Alveolar Rhabdomyosarcoma, Botryoid-Type Embryonal Rhabdomyosarcoma | Phase 3 | Active not recruiting | National Cancer Institute (NCI) | 325 | 2016-06-01 | 2026-10-01 |
| Trial for Localised High-risk Rhabdomyosarcoma and Rhabdomyosarcoma-like Soft Tissue Sarcoma trofosfamide, idarubicin, etoposide - Soft Tissue Sarcoma | Phase 3 | Completed | University Hospital Tuebingen | 195 | 2009-07-01 | 2022-11-08 |
| Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma Cyclophosphamide, Dactinomycin, Irinotecan Hydrochloride - Adult Rhabdomyosarcoma, Childhood Alveolar Rhabdomyosarcoma | Phase 3 | Completed | Children's Oncology Group | 481 | 2006-12-26 | 2023-01-31 |
| High-Dose Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Metastatic Rhabdomyosarcoma or Ectomesenchymoma dactinomycin, cyclophosphamide, doxorubicin hydrochloride - Sarcoma | Phase 3 | Completed | Children's Oncology Group | 109 | 2006-07-01 | 2020-01-29 |
| Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma conventional surgery, dactinomycin, cyclophosphamide - Adult Rhabdomyosarcoma, Embryonal Childhood Rhabdomyosarcoma | Phase 3 | Completed | Children's Oncology Group | 390 | 2004-09-04 | 2021-11-19 |
| Doxorubicin With or Without Ifosfamide and Pegfilgrastim in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma pegfilgrastim, doxorubicin hydrochloride, ifosfamide - Sarcoma | Phase 3 | Completed | European Organisation for Research and Treatment of Cancer - EORTC | 455 | 2003-04-01 | 2014-10-27 |
| Combination Chemotherapy in Treating Patients With Previously Untreated Rhabdomyosarcoma dactinomycin, vincristine sulfate, cyclophosphamide - Adult Malignant Mesenchymoma, Adult Rhabdomyosarcoma | Phase 3 | Completed | Children's Oncology Group | 702 | 2002-09-01 | 2013-06-17 |
| Ifosfamide or Doxorubicin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma doxorubicin hydrochloride, ifosfamide - Sarcoma | Phase 3 | Completed | European Organisation for Research and Treatment of Cancer - EORTC | 780 | 1998-01-01 | 2012-01-20 |
| Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma dactinomycin, filgrastim, sargramostim - Sarcoma | Phase 3 | Completed | Children's Oncology Group | 483 | 1997-08-01 | 2014-02-14 |
| Combination Chemotherapy With or Without Hyperthermia Therapy in Treating Patients With Soft Tissue Sarcoma doxorubicin hydrochloride, etoposide, ifosfamide - Sarcoma | Phase 3 | Completed | European Organisation for Research and Treatment of Cancer - EORTC | 340 | 1997-07-01 | 2013-09-17 |
| Rhabdomyosarcoma and Malignant Soft Tissue Tumours of Childhood Ifosfamide, oncovin, actinomycine D, epirubicine, carboplatinum, etoposide - Rhabdomyosarcoma, Malignant Soft Tissue | Phase 3 | Terminated | Gustave Roussy, Cancer Campus, Grand Paris | 400 | 1995-07-01 | 2005-09-13 |
| Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma filgrastim, doxorubicin hydrochloride, ifosfamide - Endometrial Cancer, Kidney Cancer | Phase 3 | Completed | European Organisation for Research and Treatment of Cancer - EORTC | 350 | 1995-02-01 | 2014-08-08 |
Sarcoma (9) · Sarcoma, Synovial (5) · Fibrosarcoma (4) · Hemangiosarcoma (4) · Histiocytoma, Malignant Fibrous (4) · Leiomyosarcoma (4) · Liposarcoma (4) · Malignant mesenchymal tumor (4) · Neurofibrosarcoma (4) · Rhabdomyosarcoma, Alveolar (4) · Rhabdomyosarcoma, Embryonal (4) · Hemangiopericytoma, Malignant (2) · Bone Neoplasms (1) · Endometrial Neoplasms (1)
Myosarcoma (18) · Neoplasms by Histologic Type (18) · Neoplasms, Connective and Soft Tissue (18) · Neoplasms, Muscle Tissue (18) · Neoplasms (17) · Sarcoma (9) · Neoplasms, Connective Tissue (5) · Histiocytoma (4) · Neoplasms, Adipose Tissue (4) · Neoplasms, Fibrous Tissue (4) · Neoplasms, Nerve Tissue (4) · Neoplasms, Vascular Tissue (4) · Nerve Sheath Neoplasms (4) · Nervous System Diseases (4) · Nervous System Neoplasms (4)
Radiotherapy (11) · Vincristine (10) · Cyclophosphamide (9) · Dactinomycin (9) · Radiation (7) · Ifosfamide (6) · Doxorubicin (5) · Etoposide (4) · Filgrastim (4) · Irinotecan (4) · Biopsy (3) · Magnetic Resonance Spectroscopy (3) · Vinorelbine (3) · Granulocyte Colony-Stimulating Factor (2) · Specimen Handling (2)
Children's Oncology Group (8) · European Organisation for Research and Treatment of Cancer - EORTC (4) · Goldman, Butterwick, Fitzpatrick and Groff (1) · Gustave Roussy, Cancer Campus, Grand Paris (1) · N.N. Petrov National Medical Research Center of Oncology (1) · National Cancer Institute (NCI) (1) · University Hospital Tuebingen (1) · Yizhuo Zhang (1)
Canada (10) · United States (10) · Australia (7) · Switzerland (7) · Puerto Rico (6) · Germany (5) · New Zealand (5) · France (4) · Netherlands (4) · Austria (3) · Belgium (3) · Denmark (3) · Slovakia (3) · Spain (3) · United Kingdom (3)
Abha A Gupta (1) · Brenda Weigel, MD (1) · Carola A Arndt, MD (1) · Carola Arndt (1) · Christine M Heske (1) · David Walterhouse, MD (1) · Douglas S Hawkins (1) · Ewa Koscielniak, MD (1) · Ian R. Judson, MA, MD, FRCP (1) · Josephine H Haduong (1) · Monika Sparber Sauer, MD (1) · Paul C. Lorigan, MD (1) · Penella J. Woll, MD, PhD (1)
PMID 38603649, PMID 17634494, PMID 18286501, PMID 20434400, PMID 21357783, PMID 22104356, PMID 22954508, PMID 24618336, PMID 24747207, PMID 29450452, PMID 30091945, PMID 31174239, PMID 34666214, PMID 35829629, PMID 38936378, PMID 39687431, PMID 41914453, PMID 42035475
U10CA180886 (5), U10CA098543 (3)